Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance Study

INTRODUCTION: A post-marketing surveillance (PMS) study was conducted to confirm the long-term risk–benefit profile of sitagliptin administered to Japanese patients with type 2 diabetes mellitus (T2DM) under real-world conditions. METHODS: This prospective, multicentre, open-label PMS collected data...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshikawa, Ken, Tsuchiya, Akira, Kido, Tomoyuki, Ota, Tomohiro, Ikeda, Keiko, Iwakura, Mika, Maeda, Yoshikazu, Maekawa, Shinichiroh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467485/
https://www.ncbi.nlm.nih.gov/pubmed/32306246
http://dx.doi.org/10.1007/s12325-020-01293-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467485/
https://www.ncbi.nlm.nih.gov/pubmed/32306246
http://dx.doi.org/10.1007/s12325-020-01293-2

Ejemplares similares